Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biopeptides is a biotechnology company specializing in the design, synthesis, and development of high-quality peptides for research and therapeutic applications. The company provides a range of services including custom peptide synthesis, modification, and analytical characterization to support academic and industrial drug discovery efforts. By leveraging advanced solid-phase and liquid-phase synthesis techniques, Biopeptides offers specialized products such as isotope-labeled peptides and complex cyclic structures. Their expertise facilitates the exploration of peptide-based therapeutics across various disease areas, serving as a critical partner for organizations focused on molecular biology and pharmacology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biopeptides.